Therapeutic controversies in bilateral breast cancer [2]

Clinical Oncology

Volumn 15, Issue 5, 2003, Pages 297-298

  Deo, S V S ^a   Shridhar, D ^a   Purkayastha, J ^a   Bhutani, M ^a   Shukla, N K ^a   Raina, V ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ADVANCED CANCER; BILATERAL CANCER; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; HUMAN; LETTER; MASTECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0041629415     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(03)00111-0     Document Type: Letter

References (3)

1. Haagensen CD (editor). Diseases of the breast, 3rd edn, Philadelphia, PA: WB Saunders Company, 1985:440-461.
2. Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984;71:711-714.
3. Rochefordiere AD, Asselain B, Scholl S, et al. Simultaneous bilateral breast carcinomas: a retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994;30:35-41.